BioFD&C Co Ltd (251120)

KOSDAQ

Currency in KRW

14,430

-60(-0.41%)

Closed·02:29:59

Fair Value

Unlock Value

Day's Range

14,250

14,490

52 wk Range

12,500

23,100

251120 Income Statement

Assess the BioFD C income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 251120 net worth.

Period Ending:

2015

31/12

2016

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

11,972.17

15,855.32

15,592.09

16,066.43

19,179.05

Total Revenues Growth

aa.aa

+38.57%

+32.43%

-1.66%

+3.04%

+19.37%

Cost Of Revenues

aa.aa

4,895.34

4,859.12

4,562.78

4,852.2

6,305.04

Gross Profit

aa.aa

7,076.84

10,996.2

11,029.31

11,214.23

12,874.01

Gross Profit Growth

aa.aa

+26.19%

+55.38%

+0.3%

+1.68%

+14.8%

Gross Profit Margin %

aa.aa

59.11%

69.35%

70.74%

69.8%

67.13%

Other Operating Expenses, Total

aa.aa

3,939.3

6,115.57

5,995.31

6,361.65

6,621.25

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+46.81%	+55.25%	-1.97%	+6.11%	+4.08%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	815.9	1,449.27	1,428.89	1,698.51	1,651.67
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,959.4	4,538.36	4,323.03	4,305.25	4,547.85
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	48.93	-	-	-	-

Operating Income

aa.aa

3,137.54

4,880.64

5,034

4,852.58

6,252.76

Operating Income Growth

aa.aa

+7.28%

+55.56%

+3.14%

-3.6%

+28.85%

EBIT Margin %

aa.aa

26.21%

30.78%

32.29%

30.2%

32.6%

Net Interest Expenses

aa.aa

-31.34

455.11

970.26

1,270.28

1,184.45

Net Interest Expenses Growth

aa.aa

-132.97%

+1,552.21%

+113.19%

+30.92%

-6.76%

Interest Expense, Total

aa.aa

-62.29

-108.93

-127.82

-63.47

-38.94

Interest And Investment Income

aa.aa

30.95

564.04

1,098.08

1,333.75

1,223.39

Other Non Operating Expenses, Total

aa.aa

178.18

111.25

-23.04

211.4

-36.99

EBT, Excl. Unusual Items

aa.aa

3,284.38

5,446.99

5,981.22

6,334.25

7,400.22

Gain (Loss) On Sale Of Assets

aa.aa

8.88

0.43

-0.19

18.18

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

3,293.25

5,443.36

7,151.94

5,227.62

7,949.71

EBT, Incl. Unusual Items Growth

aa.aa

+14.29%

+65.29%

+31.39%

-26.91%

+52.07%

EBT, Incl. Unusual Items Margin

aa.aa

27.51%

34.33%

45.87%

32.54%

41.45%

Income Tax Expense

aa.aa

385.7

1,108.1

1,566.79

726.69

1,283.51

Net Income to Company

aa.aa

2,907.55

4,335.26

5,585.15

4,500.92

6,666.2

Minority Interest

aa.aa

Net Income

aa.aa

2,907.55

4,335.26

5,585.15

4,500.92

6,666.2

Net Income Growth

aa.aa

+18.12%

+49.1%

+28.83%

-19.41%

+48.11%

Net Income Margin %

aa.aa

24.29%

27.34%

35.82%

28.01%

34.76%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

2,907.55

4,335.26

5,585.15

4,500.92

6,666.2

Basic EPS - Continuing Operations

aa.aa

394

492

654.85

528

782

Basic EPS - Continuing Operations Growth

aa.aa

+17.96%

+24.87%

+33.1%

-19.37%

+48.11%

Diluted EPS - Continuing Operations

aa.aa

393

492

654.85

528

781

Diluted EPS - Continuing Operations Growth

aa.aa

+17.66%

+25.19%

+33.1%

-19.37%

+47.92%

Basic Weighted Average Shares Outstanding

aa.aa

7.38

8.81

8.53

8.52

Diluted Weighted Average Shares Outstanding

aa.aa

7.4

8.81

8.53

8.52

8.54

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

3,763.58

5,929.61

6,121.14

6,065.52

7,573.76

EBITDA Growth

aa.aa

+6.66%

+57.55%

+3.23%

-0.91%

+24.87%

EBITDA Margin %

aa.aa

31.44%

37.4%

39.26%

37.75%

39.49%

EBIT

aa.aa

3,137.54

4,880.64

5,034

4,852.58

6,252.76

* In Millions of KRW (except for per share items)

FAQ

What was BioFD C’s revenue at year end?

At the end of the last reported fiscal year, BioFD C (251120) recorded total revenue of 19,179 million KRW.

How much revenue did BioFD C report in the most recent quarter?

In its most recent quarterly earnings report, BioFD C posted revenue of 5,103 million KRW.

What was BioFD C’s net income for the year?

For the full year, BioFD C reported net income of 6,666 million KRW.

How much net income did BioFD C post in the last quarter?

In the most recent quarter, BioFD C (251120) posted net income of 1,336 million KRW.

What was BioFD C’s gross profit for the year?

Gross profit for the year was reported at 12,874 million KRW.

How much gross profit did BioFD C generate last quarter?

BioFD C recorded gross profit of 2,971 million KRW in its latest quarterly report.

What was BioFD C’s annual operating income?

For the full year, BioFD C (251120) reported operating income of 6,253 million KRW.

What was BioFD C’s operating income last quarter?

Quarterly operating income was 1,274 million KRW.

What was BioFD C’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 1,628 million KRW.

What was the quarter-over-quarter change in EBITDA for BioFD C?

EBITDA changed by -20% million KRW compared to the last quarter.

What is BioFD C’s most recent gross profit margin?

The latest reported gross profit margin for BioFD C (251120) is 58% million KRW.

What is BioFD C’s most recent net income margin?

Net income margin based on recent financials is 26% million KRW.

What is BioFD C’s most recent EBIT margin?

BioFD C reported an EBIT margin of 25% million KRW based on current figures.

How did BioFD C’s revenue change compared to the previous quarter?

Revenue changed by 1% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for BioFD C?

In the latest quarter, gross profit changed by -13% million KRW from the previous quarter.

S&P/TSX

33,640.74

-177.45

-0.52%

S&P/TSX 60

1,962.71

-6.00

-0.30%

US 30

49,201.60

+33.6

+0.07%

US 500

7,131.50

-42.5

-0.59%

S&P 500 VIX

18.25

+0.23

+1.28%

DAX

24,040.29

-43.24

-0.18%

Dollar Index

98.445

+0.127

+0.13%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	31.67	+1.38%	13.96M
ARC Resources	31.65	+1.38%	10.00M
RBC	243.06	+0.95%	3.32M
Bank of Montreal	207.96	+0.08%	3.05M
Canadian Natural	63.63	+3.58%	2.84M
Toronto Dominion Bank	144.96	+0.57%	1.22M
Celestica Inc.	486.00	-15.73%	687.77K

Name	Last	Chg. %	Vol.
Vector Science Therapeutics	0.44	+780.00%	99.60K
PeakBirch Logic	0.030	+500.00%	1.32K
Irwin Naturals	0.30	+150.00%	3.24K
Dixie Gold	0.0350	+133.33%	1.65M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
INEO Tech	0.0100	+100.00%	1.01M
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Montfort Capital	0.0050	-66.67%	472.92K
Resource Centrix Holdings	1.50	-60.00%	600.00
Dixie Gold	0.035	-56.25%	2.00K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Blue Horizon Global Capital	0.005	-50.00%	12.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	487.00	-15.56%	685.66K
ARC Resources	31.66	+1.41%	9.99M
TELUS	16.90	+1.93%	5.72M
Canadian Natural	63.61	+3.55%	2.83M
Canadian Imperial Bank	150.16	-0.31%	771.13K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa Aaaaaaa	5.17	+66.53%	8.61
Aaa A Aaaaa	5.96	+55.33%	9.26
Aaa Aaaaaaaa Aaaa	100.83	+54.36%	155.64
Aaaaaaaaaaaa A	2,440.00	+49.94%	3,658.54
Aa Aaaaa A	10.65	+43.78%	15.31
Aa Aa A Aa	113.05	+39.81%	158.06
Aaaaaa Aaa	23.21	+39.51%	32.38

Name	Last	Upside	Fair Value
Aaaaaaa Aaaaaaa	5.17	+66.53%	8.61
Aaa A Aaaaa	5.96	+55.33%	9.26
Aaa Aaaaaaaa Aaaa	100.83	+54.36%	155.64
Aaaaaaaaaaaa A	2,440.00	+49.94%	3,658.54
Aa Aaaaa A	10.65	+43.78%	15.31
Aa Aa A Aa	113.05	+39.81%	158.06
Aaaaaa Aaa	23.21	+39.51%	32.38

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

BioFD&C Co Ltd (251120)

251120 Income Statement

FAQ

What was BioFD C’s revenue at year end?

How much revenue did BioFD C report in the most recent quarter?

What was BioFD C’s net income for the year?

How much net income did BioFD C post in the last quarter?

What was BioFD C’s gross profit for the year?

How much gross profit did BioFD C generate last quarter?

What was BioFD C’s annual operating income?

What was BioFD C’s operating income last quarter?

What was BioFD C’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for BioFD C?

What is BioFD C’s most recent gross profit margin?

What is BioFD C’s most recent net income margin?

What is BioFD C’s most recent EBIT margin?

How did BioFD C’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for BioFD C?

Trending Stocks